• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆症和抑郁症:与淀粉样 β 蛋白的生物学联系。

Dementia and depression: Biological connections with amyloid β protein.

机构信息

Laboratory of Physiology, Pharmacology and Psychopathology, Graduate Program in Biomedical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil.

Laboratory for research into care, patient safety, and technological innovation in nursing and health, Federal University of Santa Catarina, Florianópolis, SC, Brazil.

出版信息

Basic Clin Pharmacol Toxicol. 2024 May;134(5):563-573. doi: 10.1111/bcpt.13996. Epub 2024 Mar 8.

DOI:10.1111/bcpt.13996
PMID:38459754
Abstract

Dementia is an umbrella term for a broad group of age-associated neurodegenerative diseases. It is estimated that dementia affects 50 million people worldwide and that Alzheimer's disease (AD) is responsible for up to 75% of cases. Small extracellular senile plaques composed of filamentous aggregates of amyloid β (Aβ) protein tend to bind to neuronal receptors, affecting cholinergic, serotonergic, dopaminergic and noradrenergic neurotransmission, leading to neuroinflammation, among other pathophysiologic processes and subsequent neuronal death, followed by dementia. The amyloid cascade hypothesis points to a pathological process in the cleavage of the amyloid precursor protein (APP), resulting in pathological Aβ. There is a close relationship between the pathologies that lead to dementia and depression. It is estimated that depression is prevalent in up to 90% of individuals diagnosed with Parkinson's disease, with varying severity, and in 20 to 30% of cases of Alzheimer's disease. The hypothalamic pituitary adrenal (HPA) axis is the great intermediary between the pathophysiological mechanisms in neurodegenerative diseases and depression. This review discusses the role of Aβ protein in the pathophysiological mechanisms of dementia and depression, considering the HPA axis, neuroinflammation, oxidative stress, signalling pathways and neurotransmission.

摘要

痴呆是一组与年龄相关的神经退行性疾病的统称。据估计,全球有 5000 万人患有痴呆症,其中阿尔茨海默病(AD)占病例的 75%左右。由淀粉样β(Aβ)蛋白丝状聚集组成的小细胞外老年斑倾向于与神经元受体结合,影响胆碱能、5-羟色胺能、多巴胺能和去甲肾上腺素能神经传递,导致神经炎症等病理生理过程和随后的神经元死亡,进而导致痴呆。淀粉样蛋白级联假说指出了淀粉样前体蛋白(APP)裂解导致病理性 Aβ的病理过程。导致痴呆和抑郁的病理之间存在密切关系。据估计,高达 90%的帕金森病患者、不同严重程度的患者以及 20%至 30%的阿尔茨海默病患者都患有抑郁症。下丘脑-垂体-肾上腺(HPA)轴是神经退行性疾病的病理生理机制与抑郁之间的主要中介。这篇综述讨论了 Aβ蛋白在痴呆和抑郁的病理生理机制中的作用,同时考虑了 HPA 轴、神经炎症、氧化应激、信号通路和神经传递。

相似文献

1
Dementia and depression: Biological connections with amyloid β protein.痴呆症和抑郁症:与淀粉样 β 蛋白的生物学联系。
Basic Clin Pharmacol Toxicol. 2024 May;134(5):563-573. doi: 10.1111/bcpt.13996. Epub 2024 Mar 8.
2
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
3
The pathomimetic oAβ model of Alzheimer's disease: Potential for screening of new therapeutic agents.阿尔茨海默病的拟病态oAβ模型:新型治疗药物筛选的潜力
Pharmacol Ther. 2023 May;245:108398. doi: 10.1016/j.pharmthera.2023.108398. Epub 2023 Mar 29.
4
Emerging role of amyloid beta in stress response: Implication for depression and diabetes.淀粉样β在应激反应中的新作用:对抑郁和糖尿病的影响。
Eur J Pharmacol. 2017 Dec 15;817:22-29. doi: 10.1016/j.ejphar.2017.08.031. Epub 2017 Aug 24.
5
Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.探索针对减轻阿尔茨海默病中与淀粉样蛋白-β级联相关事件的治疗剂的潜力。
Int J Mol Sci. 2020 Oct 9;21(20):7443. doi: 10.3390/ijms21207443.
6
Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade?抑郁症和阿尔茨海默病:压力是否是共同神经病理级联反应的起始因素?
J Alzheimers Dis. 2011;23(2):177-93. doi: 10.3233/JAD-2010-100390.
7
3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.3xTg-AD 小鼠在早期病理阶段表现出中枢应激轴的激活。
J Alzheimers Dis. 2013;33(2):407-22. doi: 10.3233/JAD-2012-121438.
8
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.阿尔茨海默病的病理生理学和治疗干预的最新进展。
Curr Pharm Des. 2023;29(43):3428-3441. doi: 10.2174/0113816128264355231121064704.
9
Current Views on the Role of Stress in the Pathogenesis of Chronic Neurodegenerative Diseases.当前对压力在慢性神经退行性疾病发病机制中的作用的看法。
Biochemistry (Mosc). 2021 Jun;86(6):737-745. doi: 10.1134/S0006297921060110.
10
ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease.三磷酸腺苷敏感性钾通道抑制剂格列本脲可减轻阿尔茨海默病大鼠模型中 HPA 轴过度活跃、抑郁和焦虑相关症状。
Brain Res Bull. 2018 Mar;137:265-276. doi: 10.1016/j.brainresbull.2018.01.001. Epub 2018 Jan 4.

引用本文的文献

1
Shared Mechanisms in Dementia and Depression: The Modulatory Role of Physical Exercise.痴呆与抑郁的共同机制:体育锻炼的调节作用
J Neurochem. 2025 Aug;169(8):e70185. doi: 10.1111/jnc.70185.
2
Oxytocin Intervention Mitigates Pathological and Behavioral Impairments in APP/PS1 Mice Subjected to Early Social Isolation.催产素干预减轻早期社会隔离的APP/PS1小鼠的病理和行为损伤。
CNS Neurosci Ther. 2025 Jul;31(7):e70511. doi: 10.1111/cns.70511.
3
Exploring the Relationship Between Amyloid Burden and Depression in Pre-clinical Alzheimer's Disease.
探索临床前阿尔茨海默病中淀粉样蛋白负荷与抑郁之间的关系。
Cureus. 2024 Sep 19;16(9):e69716. doi: 10.7759/cureus.69716. eCollection 2024 Sep.
4
Glucose Metabolic Abnormality: A Crosstalk between Depression and Alzheimer's Disease.葡萄糖代谢异常:抑郁症与阿尔茨海默病之间的相互作用
Curr Neuropharmacol. 2025;23(7):757-770. doi: 10.2174/011570159X343281240912190309.
5
Investigating the molecular mechanisms underlying the co-occurrence of Parkinson's disease and inflammatory bowel disease through the integration of multiple datasets.通过整合多个数据集,研究帕金森病和炎症性肠病同时发生的分子机制。
Sci Rep. 2024 Jul 24;14(1):17028. doi: 10.1038/s41598-024-67890-1.
6
Molecular signatures of premature aging in Major Depression and Substance Use Disorders.重度抑郁症和物质使用障碍中的早衰分子特征。
Sci Data. 2024 Jun 26;11(1):698. doi: 10.1038/s41597-024-03538-z.
7
Technical Report: Efficacy and Safety of Low-Intensity Transcranial Magnetic Stimulation in the Remission of Depressive Symptoms in Patients With Treatment-Resistant Depression in Mexico.技术报告:低强度经颅磁刺激对墨西哥难治性抑郁症患者抑郁症状缓解的疗效与安全性
Cureus. 2024 May 3;16(5):e59612. doi: 10.7759/cureus.59612. eCollection 2024 May.